Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), the best-performing Nasdaq-traded biotech stock of 2016, is on the move again. Data from a phase II trial of its flagship cannabinoid Resunab on cystic fibrosis is due any day now. This time though, it is not just retail investors getting in front of the news. Corbus is now drawing a large amount of institutional attention from several directions.
Since Eric Reis first coined the term “Lean Startup” in 2008, businesses have followed a consistent trajectory: Get flat or go home. The over-structured bureaucracy so common in 20th-century corporations is anathema to startups today, and a company might seem downright puritanical if its CEO doesn’t stroll into work wearing a hoodie.
Related CHTR 15 Biggest Mid-Day Gainers For Monday 22 Stocks Moving In Monday's Pre-Market Session Is Softbank Eyeing Charter Bid, Shotgun Marriage For Sprint? (Investor’s Business Daily)
Related GME 22 Stocks Moving In Monday's Pre-Market Session Pro: These Tech Investment Ideas Are 'Scary'....More>>>
All main U.S. stock indexes closed higher on Tuesday, with the Dow finishing at its 47th record for 2017, as optimism appeared to grow ahead of the start of the earnings season, which will provide concrete insight into the state of U.S. corporations.
Apple (NASDAQ:AAPL) Pay Cash Card could increase Apple’s take-rate by 9 times, thereby accelerating the future growth of Apple’s Services revenue segment. With Apple Pay growing at 500% y/y, in a few years, Apple Pay Cash could add an incremental $1 billion to revenue. And given the infrastructure and cost per transaction not likely changing, we believe that most of this $1 billion will....More>>>
Fitbit (NYSE:FIT) recently announced an executive shakeup and business realignment to “reignite growth” at the struggling wearables maker, which lostmore than 60% of its market value over the past 12 months. Chief Business Officer Woody Scal andExecutive VP Tim Roberts, who oversaw the company’s social networking efforts, announced that they would step down at the end of March.....More>>>
Intrexon (XON) has made a small yet strategic acquisition in buying GenVec (GNVC); with the purchase, XON gets AdenoVerse, a platform of adenovirus vectors for delivering drugs and vaccines that dovetails nicely with its existing suite of gene therapy technologies, suggests John McCamant, editor of The Medical Technology Stock Letter.
The ability to increase the payloads of viral vectors....More>>>
Our primary theme for Corning’s (NYSE:GLW) shares as an investment has been a theme of transformation towards balancing revenue/earnings across all of its divisions more evenly and lessening dependence on the company’s price sensitive LCD glass business. This transformation is being accomplished in two ways. One way is the company’s ongoing acquisitions to fold into its non-display....More>>>
After the Reserve Bank of Indias Monetary Policy Committee (MPC) decided to keep key interest rates unchanged, rate-sensitive stocks on Thursday surged ahead on the back of central banks dovish policy stance.
Rate sensitive stocks are usually the ones who are directly impacted by the ce
Dunkin' Brands Group(NASDAQ:DNKN) reports its second-quarter 2018 results next week on July 26.The quick-service restaurant chain has chalked up a stock price return of 35% over the last 12 months, due in part to investors' confidence in its strategy of investing in franchisee growth.
CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic st
CryoPort (NASDAQ: CYRX) and C. H. Robinson (NASDAQ:CHRW) are both transportation companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendat